Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
    • The aesthetic impact of medication-driven weight loss
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Home
  • Investors

Cetaphil® Champions Sun Protection Awareness and Education with Dermatologist-led Digital Campaign

Press release

Galderma receives FDA approval for Restylane® Contour for cheek augmentation and correction of midface contour deficiencies

Press release

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

Press release

Cetaphil® Announces Major Evolution in Brand’s Mission to Advance Sensitive Skin Science

Press release

RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers

Press release

Galderma leads oral presentation on hyaluronic acid filler safety insights at ASDS 2021 Annual Meeting

Press release

Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners

Press release

Galderma announces relocation of U.S. Headquarters to downtown Dallas

Press release

Differin® Joins Forces with Expert Digital Voices to Kickstart the Acne Conversation for Its Fifth-Annual Retinoid Education Week

Press release

Cetaphil® Champions Sensitive Skin Initiative with an Entire Month of Science-Backed Educational Content

Press release

Pagination

  • Previous page Previous Page
  • Next page Next Page
Subscribe to U.S. release
  1. Home
  2. U.S. release

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2025

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back